Revenue segments as reported by the company.

Waters

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling and administrative expenses

Research and development expenses

Purchased intangibles amortization

Asset impairment

Litigation provision

Acquired in-process research and development

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Waters Corp. engages in the provision of workflow solutions involving liquid chromatography, mass spectrometry, and thermal analysis. It operates through the Waters and TA (TA Instruments) segments. The Waters segment consists of liquid chromatography instruments, mass spectrometry, and precision chemistry consumable products and services. The TA segment products and services include thermal analysis, rheometry and calorimetry instrument systems, and service sales. The company was founded by James Logan Waters in 1958 and is headquartered in Milford, MA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Waters reports robust Q4 earnings, eyes growth through acquisitions

Waters Corporation's strong performance in Q4 2022 and full-year results, coupled with the Wyatt Technology acquisition, positions the company for continued growth.
Despite challenges in China and FX headwinds, Waters sees opportunities in pricing increases, revenue synergies from acquisitions, and growth in bioanalytical applications.

Waters Corp reports Q1 revenue growth below expectations, eyes biotech

Waters Corporation faces challenges from weaker demand in key sectors but maintains strengths in certain divisions and sustainability efforts. The acquisition of Wyatt Technology presents growth opportunities, with a focus on maintaining pricing strength and capitalizing on ongoing pharma activity.

Waters (WAT) reports robust Q2 growth, eyes Chinese market recovery

Waters Corporation delivered strong Q2 performance with 5% constant currency growth and non-GAAP EPS above expectations, driven by operational excellence and margin expansion.
While challenges persist in the China Pharma market and cautious spending trends impact growth outlook, Waters remains well-positioned for growth above market rates.
The company's strategic strengths in innovation, execution, and margin expansion, coupled with growth opportunities in key segments and regions, position it for continued success.

Waters expands margins amidst China challenges, eyes service growth

Waters Corporation navigated through challenges in China, focusing on margin expansion, cost management, and workforce optimization. Despite headwinds, the company showcased resilience, positive cash flow, and growth opportunities in service attachment rates and e-commerce sales.

Waters faces sales decline in Q4 2023, eyes PFAS market

Waters navigated a challenging Q4 2023 with sales decline and cautious Q1 2024 guidance. Despite China's struggles, the company's operational resilience and focus on sustainability are strengths. Opportunities lie in PFAS testing, e-commerce growth, and large molecule applications.

Waters Corp exceeds EPS guidance, eyes China stimulus for growth

Waters Corporation's Q1 2024 performance was solid, with a focus on margin expansion and innovation. Challenges include sales decline and concerns about revenue targets. Opportunities exist in China's pharma market stabilization and margin progression.

Waters Corporation surpasses Q2 expectations, eyes long-term growth strategies

Waters Corporation delivered strong Q2 results, exceeding expectations with resilient margins.
While facing sales declines, the company showcased operational efficiency and strategic focus.
Guidance reflects caution on ex-China markets but highlights opportunities for growth.
Strategic flexibility in debt management and product innovation position the company for long-term success.

Waters Corporation excels in Q3, eyes growth in key markets

Waters Corporation's strong Q3 performance exceeded expectations, driven by sales growth in key sectors and recurring revenue expansion.
Despite challenges like China sales decline and negative sales growth projections, the company remains optimistic about future opportunities.
With a focus on operational excellence, strategic positioning, and market confidence, Waters is poised for continued success and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Waters Corporation (NYSE:WAT ) Q3 2022 Earnings Conference Call November 1, 2022 8:00 AM ET Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President and Chief Executive Officer Amol Chaubal - SVP, Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Dan Brennan - Cowen and Company Matt Sykes - Goldman Sachs Luke Sergott - Barclays Rachel Vatnsdal - JPMorgan Mike Ryskin - Bank of America Merrill Lynch Operator Good morning and welcome to the Waters Corporation Third Quarter 2022 Financial Results Conference Call. All participants will be in a listen-only mode until the question-and-answer session of today's call.

Waters Corporation (WAT) Q3 2022 Earnings Call Transcript

Waters (WAT) delivered earnings and revenue surprises of 2.72% and 4.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Waters (WAT) Surpasses Q3 Earnings and Revenue Estimates

Waters Corporation (NYSE: WAT) Reports Third Quarter 2022 Financial Results

Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Waters (WAT) Q3 Earnings Expected to Decline

Waters (WAT) unveils the Extraction+ Connected Device for the Waters Andrew+ Pipetting Robot. The device automates solid phase extraction methods, saving bench time for each sample set.

Waters (WAT) to Attract Scientists With Extraction+ Device

Mettler-Toledo

PerkinElmer

The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD), Waters (WAT) and PerkinElmer (PKI) are gaining from strong life science, pharmaceutical and academic end-market demand, as well as rising healthcare spending.

3 Stocks to Watch on Rising Demand for Scientific Instruments

MILFORD, Mass.--(BUSINESS WIRE)-- #separationscience--Waters introduces Extraction+, a new connected device for the Andrew+ Pipetting Robot that automates solid phase extraction sample preparation methods

Waters Automates Solid Phase Extraction of Biological, Food and Environmental Samples with Andrew+ Pipetting Robot

WEXFORD, Ireland--(BUSINESS WIRE)-- #ClinicalDx--Waters Corporation commits multi-year investment with support from IDA Ireland to help accelerate life sciences industry growth in the South East.

Waters Marks 25 Years in Ireland with €6 Million Clinical Diagnostics R&D Center Expansion in Wexford

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) will hold its Q3 2022 financial results conference call live on Tuesday, November 1st 2022 at 8:00 a.m. eastern time. A live webcast of the presentation will be available on Waters' investor relations website at https://ir.waters.com. A replay of the webcast will also be available until at least November 15th, 2022, at midnight eastern time. About Waters Corporation Waters Corporation (NYSE:WAT), a global leader in analytical instru

Waters Corporation Schedules Third Quarter 2022 Earnings Conference Call

MILFORD, Mass.--(BUSINESS WIRE)---- $WAT #lithiumionbatteries--Waters Corporation (NYSE:WAT) today introduced new, innovative powder rheology tooling and software for its TA Instruments™ HR Rheometers allowing scientists to make preciseii, repeatable powder rheology measurements simpler and faster. Such measurements enable materials scientists to optimize the processing and end-use performance of powders used in batteries, pharmaceuticals, additive manufacturing, food, personal care products, and coatings. “Powder materials

Waters Extends Capabilities of Flagship TA Instruments Rheometer for Efficient and Repeatable Powder Analysis

MILFORD, Mass.--(BUSINESS WIRE)-- #LEED--Waters Corp. announces its new $215M Precision Chemical Manufacturing Facility is the first of its kind in Massachusetts to achieve LEED certification

Waters Announces Bay State's First LEED-Certified Chemical Manufacturing Facility

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) Udit Batra Ph.D., President and Chief Executive Officer, will participate at the Bank of America 2022 Global Healthcare Conference in London, with a fireside chat on Wednesday, September 14th, 2022 at 9:05AM BST (UTC+1) / 4:05AM ET. Interested investors can access the live webcast of the event on Waters' investor relations website at https://ir.waters.com. A replay of the webcast will be available for 30 days. About Waters Corporati

Waters Corporation Presentation at the Bank of America 2022 Global Health Care Conference

Waters (WAT) reported earnings 30 days ago. What's next for the stock?

Why Is Waters (WAT) Down 11.9% Since Last Earnings Report?

Waters Corporation (NYSE:WAT ) Q2 2022 Earnings Conference Call August 2, 2022 8:00 AM ET Company Participants Caspar Tudor - Manager of IR Udit Batra - President & CEO Amol Chaubal - SVP & CFO Conference Call Participants Vijay Kumar - Evercore Luke Sergott - Barclays Daniel Brenna - Cowen Matthew Sykes - Goldman Sachs Josh Waldman - Cleveland Research Rachel Vatnsdal - JPMorgan Derik De Bruin - Bank of America Puneet Souda - SVB Securities Brandon Couillard - Jefferies Patrick Donnelly - Citi Operator Good morning. Welcome to the Waters Corporation Second Quarter 2022 Financial Results Conference Call.

Waters Corporation (WAT) CEO Udit Batra on Q2 2022 Results - Earnings Call Transcript

Waters' (WAT) second-quarter results reflect gains from a strong momentum across pharmaceutical and industrial end-markets, and geographical regions.

Waters (WAT) Q2 Earnings & Sales Surpass Estimates, Rise Y/Y

Waters (WAT) delivered earnings and revenue surprises of 4.56% and 1.24%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Waters (WAT) Beats Q2 Earnings and Revenue Estimates

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE: WAT) today announced its financial results for the second quarter of 2022. “Our team's strong focus on execution continued to deliver excellent results, despite the challenging macroeconomic environment, with instrument sales growing 12% and recurring revenues growing 8% in constant currency in the second quarter. The sustained commercial momentum and broad-based growth in each of our regions reflects continued strong customer demand ac

Waters Corporation (NYSE: WAT) Reports Second Quarter 2022 Financial Results

Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Waters (WAT) Earnings Expected to Grow: Should You Buy?

MILFORD, Mass.--(BUSINESS WIRE)-- #alternativeproteins--Waters Corporation (NYSE:WAT) announced it is providing both technology and expertise to help advance plant-based protein science in collaboration with researchers of the Plant Protein Innovation Center (PPIC) at the University of Minnesota. Waters scientists will work with PPIC researchers to develop a workflow for measuring the amino acid content of plant-based proteins using a Waters ACQUITY™ Premier UPLC System. Waters is the first analytical instrument comp

Waters Collaborates with Leading Researchers and Industry Partners to Advance the Science of Alternative Proteins

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) will hold its Q2 2022 financial results conference call live on Tuesday, August 2nd 2022 at 8:00 a.m. eastern time. A live webcast of the presentation will be available on Waters' investor relations website at https://ir.waters.com. A replay of the webcast will also be available until at least August 16th 2022 at midnight eastern time. About Waters Corporation Waters Corporation (NYSE:WAT), a global leader in analytical instruments

Waters Corporation Schedules Second Quarter 2022 Earnings Conference Call

DocuSign

Fortune Brands Home & Security

Paychex

Qorvo

Teradyne

Zebra Technologies

These are seven great stocks to buy in anticipation for the start of an up move in share value in the coming weeks.

7 Stocks to Buy for a Summer Rally

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why Waters (WAT) is a Top Growth Stock for the Long-Term

SEOUL, South Korea--(BUSINESS WIRE)-- #bioanalysis--Waters Corporation announced a collaboration with BioInfra, a CRO based in South Korea, to jointly establish the ASEAN Academy for Bioanalysis.

Waters and BioInfra Establish the ASEAN Academy for Bioanalysis to Promote Analytical Skills Development

Genuine Parts

PBF Energy

RingCentral

One must follow rating upgrades by brokers as they have a deeper understanding of the stocks. We choose PBF Energy (PBF), Genuine Parts (GPC), RingCentral (RNG) and Waters (WAT) as these witness ratings upgrades.

4 Stocks With Upgraded Broker Ratings to Consider Right Now

MINNEAPOLIS--(BUSINESS WIRE)-- #ASMS2022--Waters Corporation unveiled new instruments, software and product enhancements at the American Society for Mass Spectrometry 2022 Annual Conference.

News for Waters Stock (WAT)